✦ LIBER ✦

Aripiprazole augmentation in treatment-refractory obsessive–compulsive disorder

✍ Scribed by Rahul Sarkar; Julia Klein; Stephanie Krüger

Book ID: 105882300
Publisher: Springer
Year: 2008
Tongue: English
Weight: 57 KB
Volume: 197
Category: Article
ISSN: 0033-3158
DOI: 10.1007/s00213-008-1091-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A systematic review: antipsychotic augme

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

✍ Bloch, M H; Landeros-Weisenberger, A; Kelmendi, B; Coric, V; Bracken, M B; Leckm 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 152 KB

A systematic review: antipsychotic augme

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

✍ Bloch, M H; Landeros-Weisenberger, A; Kelmendi, B; Coric, V; Bracken, M B; Leckm 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 47 KB

Aripiprazole augmentation of incomplete

Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder

✍ Eric A. Storch; Heather Lehmkuhl; Gary R. Geffken; Alexis Touchton; Tanya K. Mur 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

N-acetylcysteine augmentation in seroton

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder

✍ Lafleur, Daniel L. (author);Pittenger, Christopher (author);Kelmendi, Ben (autho 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 113 KB

N-acetylcysteine augmentation in seroton

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder

✍ Lafleur, Daniel L. (author);Pittenger, Christopher (author);Kelmendi, Ben (autho 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 113 KB

Amisulpiride augmentation in treatment r

Amisulpiride augmentation in treatment resistant obsessive–compulsive disorder: an open trial

✍ Özmen Metin; Kemal Yazici; Senel Tot; Aylin Ertekin Yazici 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

## Abstract Despite the effectiveness of clomipramine and selective serotonin reuptake inhibitors (SSRIs) in the treatment of obsessive–compulsive disorder (OCD), 40% to 60% of patients who receive an adequate treatment with these agents have significant persisting symptoms. Newer atypical antipsyc